rs7717955: Understanding This Genetic Variant and Sleep Apnea
The genetic variant rs7717955 is a single nucleotide polymorphism (SNP) located in an intergenic region of the human genome. Research has identified a statistical association between this variant and a decreased risk of obstructive sleep apnea (OSA) in specific male populations.
What each genotype means
Lower obstructive sleep apnea risk
Research indicates that this genotype is associated with a decreased risk of obstructive sleep apnea in male populations. This variant is located in the interleukin 7 receptor (IL7R) gene region, though the exact biological mechanism remains under investigation.
This is a common variant, though specific frequency data for this genotype varies by ancestral population.
Average risk profile
This genotype represents a heterozygous state for the rs7717955 variant. While the variant is associated with a decreased risk of obstructive sleep apnea in men, the presence of one copy of each allele suggests an intermediate profile compared to homozygous individuals.
This is a common variant, though specific frequency data for this genotype varies by ancestral population.
Baseline risk profile
This genotype represents the alternative homozygous state for the rs7717955 variant. Current research highlights this variant's association with a decreased risk of obstructive sleep apnea in men, and individuals without the protective allele may not share this specific genetic association.
This is a common variant, though specific frequency data for this genotype varies by ancestral population.
What is rs7717955?
A single nucleotide polymorphism, or SNP, is a variation at a single position in a DNA sequence among individuals. The variant rs7717955 is located in an intergenic region, meaning it sits in the DNA sequence between known genes rather than within a gene that codes for a protein. Because it is intergenic, it does not directly alter the structure of a protein. Instead, researchers often investigate such variants to see if they influence the regulation of nearby genes or serve as markers for other functional changes in the genome. In the case of rs7717955, its location has been noted in studies examining the genetic architecture of sleep-related disorders, specifically in relation to the interleukin 7 receptor (IL7R) gene region.
Research and Associations
The evidence linking rs7717955 to obstructive sleep apnea is considered limited and context-specific. A large-scale study published in 2024 analyzed thousands of men and found that this variant was associated with a reduced risk for OSA. While this statistical association is notable, it is important to recognize that OSA is a complex, multifactorial condition influenced by a wide array of genetic, environmental, and lifestyle factors, such as body mass index and craniofacial structure. Most genetic variants identified in genome-wide association studies (GWAS) for complex traits like OSA show modest effect sizes. Furthermore, genetic associations can vary significantly between different ancestral groups, and findings in one specific cohort may not necessarily replicate across broader, more diverse populations.
Understanding Your Results
It is essential to understand that a genetic association is not a medical diagnosis. Having a specific genotype for rs7717955 does not guarantee that an individual will or will not develop obstructive sleep apnea. Because this variant is associated with a complex trait, it is only one small piece of a much larger puzzle. Readers should never use information about a single SNP to make health decisions or to self-diagnose. If you have concerns about your sleep quality, snoring, or potential symptoms of sleep apnea, the most appropriate course of action is to consult with a healthcare professional. A doctor can perform clinical assessments, such as polysomnography, which are the gold standard for diagnosing sleep disorders. Genetic information should be viewed as educational context rather than a substitute for professional medical evaluation.
How common is this variant?
The rs7717955 variant is considered common across various global populations, though specific allele frequencies can vary by ancestry.
Frequently asked questions
Does having the 'favorable' genotype mean I won't get sleep apnea?
No. Genetic associations are statistical, not deterministic. Many factors, including weight, age, and anatomy, play a much larger role in the development of sleep apnea than any single genetic variant.
Is rs7717955 a diagnostic test for sleep apnea?
No. There is no genetic test that can diagnose obstructive sleep apnea. Diagnosis is based on clinical symptoms and physiological testing, such as a sleep study.
Why is this variant only associated with men in some studies?
Genetic studies often stratify by sex because the prevalence and presentation of conditions like sleep apnea can differ significantly between men and women. Researchers look for sex-specific associations to better understand the biological mechanisms involved.
Should I change my lifestyle based on this SNP?
No. You should not change your health habits based on a single SNP. Always follow evidence-based medical advice regarding sleep hygiene and overall health, and discuss any specific concerns with your doctor.
Sources & further reading
Educational information only, last refreshed 11/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7717955?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant is significantly associated with increased risk of obstructive sleep apnea and higher apnea-hypopnea index scores in men.
This variant is linked to the presence of hallucinations in patients with Parkinson's disease, suggesting a role in glymphatic system-related sleep disturbances.
This common variant is associated with seasonal affective disorder when triggered by disrupted sleep-wake cycles.
The AA genotype of this variant is associated with a lower risk of developing REM sleep behavior disorder symptoms in patients with Parkinson's disease.
This SNP in the TFCP2L1 gene was identified as a novel genome-wide significant marker for Behcet's disease, a vision-threatening form of uveitis.
This variant in the JRKL/CTCN5 region is a reported genetic marker associated with Behcet's disease susceptibility.